STAGE IIIA BLADDER CANCER AJCC V8
Clinical trials for STAGE IIIA BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to spare bladders in cancer patients
Disease control Recruiting nowThis phase II trial is testing whether giving the immunotherapy drug pembrolizumab along with radiation therapy after chemotherapy can help patients with muscle invasive bladder cancer avoid bladder removal surgery. About 111 participants who responded well to initial chemotherap…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could fewer radiation sessions be just as effective for bladder cancer?
Disease control Recruiting nowThis study compares two radiation schedules for people with muscle-invasive bladder cancer who also receive chemotherapy. One group gets the usual number of radiation treatments, while the other gets fewer, higher-dose sessions. The goal is to see if the shorter course works just…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New Bladder-Sparing combo could change how we treat aggressive bladder cancer
Disease control Recruiting nowThis study tests a new treatment for muscle-invasive bladder cancer that aims to save the bladder. It combines two drugs (enfortumab vedotin and pembrolizumab) with targeted radiation. About 47 adults with this cancer will receive the therapy to see if it can shrink tumors and av…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for bladder cancer patients who can't have standard chemo
Disease control Recruiting nowThis study tests two drugs, futibatinib and durvalumab, given before surgery to remove the bladder in people with muscle-invasive bladder cancer who cannot take standard chemotherapy. The goal is to see if this combination can eliminate or shrink the cancer enough to improve outc…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
A simple blood draw could detect bladder Cancer's return — a trial puts it to the test
Knowledge-focused Recruiting nowThis study tests whether a blood test that looks for tumor DNA can detect if bladder cancer has come back after treatment. Researchers will collect blood, urine, and tissue samples from 100 people with muscle-invasive bladder cancer to see how well the test matches standard metho…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC